All Tools and Resources

Antimicrobial Resistance in Low and Middle Income Countries: An Analysis of Surveillance Networks

Document

This report describes a wide array of 105 supranational networks, both past and present, concerned with AMR surveillance in LMICs. 

EDP Charter / PDE charte (English/Français)

Document

The Ebola Data Platform Charter ensures a common understanding of the mission and remit of the Platform and its Steering Committee in line with the EDP Ethics Framework. 

EDP Conflict of Interest Policy / PDE politique de gestion des conflicts d’intérêt (English/Français)

Document

This document defines what constitutes a real or perceived conflict of interest, and outlines the approach for managing conflicts as they arise.

EDP Data Access Committee Terms of Reference / PDE mandat du Comité d’accès aux données (English/Français)

Document

An overview of the purpose, structure, responsibilities and functioning of the Ebola Data Platform independent Data Access Committee.

EDP Ethics Framework / PDE cadre éthique (English/Français)

Document

An outline of the principles that guide the Ebola Data Platform to promote ethical and equitable access to data.

EDP Protocol / PDE Protocole (English/Français)

Document

A description of the aims, objectives, methods, governance and ethical considerations of the platform.

EDP Steering Committee Terms of Reference / PDE mandat du Comité de pilotage (English/Français)

Document

An overview of the purpose, structure, responsibilities and functioning of the Ebola Data Platform Steering Committee.

An evaluation of portable screening devices to assess medicines quality for national Medicines Regulatory Authorities - Supplementary Annex Book

Document
External publication

An annex of supplementary information for the full evaluation report of portable screening devices to assess medicines quality for national Medicines Regulatory Authorities.

 

Blood pharmacokinetic sample collection, processing and transport in COVID-19 clinical trials

Document

This procedure describes the process for taking pharmacokinetic (PK) samples from the phlebotomist to processing in an interim processing (e.g. ward) laboratory and onto an analytical laboratory in clinical trials.

Collection of ECG data in COVID-19 clinical trials

Document

This document provides guidance for a general process for collecting the standard 12-lead clinical trial ECG data, to support any trial-specific instructions. It does not include ambulatory (e.g. Holter) ECGs. The document, which is not prescriptive, may be adapted by sites as required.